PYXS is trading at $2.78 (7.6% down) after announcing a $114 million private placement financing priced significantly below its previous close.

  • The capital raise, led by specialist healthcare investors, is expected to extend the company's cash runway into the second quarter of 2027.
  • The deal involves issuing 19.6 million shares at $2.551 per share plus additional warrants, which is creating downward pressure in early trading sessions.